Spectral AI (MDAI) Revenue & Revenue Breakdown
Spectral AI Revenue Highlights
Latest Revenue (Y)
$19.65M
Latest Revenue (Q)
$3.79M
Spectral AI Revenue by Period
Spectral AI Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $19.65M | -33.57% |
| 2024-12-31 | $29.58M | 63.83% |
| 2023-12-31 | $18.06M | -28.82% |
| 2022-12-31 | $25.37M | 66.47% |
| 2021-12-31 | $15.24M | - |
Spectral AI generated $19.65M in revenue during NA 2025, up -33.57% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Spectral AI Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $3.79M | -25.13% |
| 2025-06-30 | $5.07M | -24.48% |
| 2025-03-31 | $6.71M | -11.80% |
| 2024-12-31 | $7.60M | -6.96% |
| 2024-09-30 | $8.17M | 9.29% |
| 2024-06-30 | $7.48M | 18.21% |
| 2024-03-31 | $6.33M | 19.65% |
| 2023-12-31 | $5.29M | 53.69% |
| 2023-09-30 | $3.44M | -19.08% |
| 2023-06-30 | $4.25M | -16.29% |
| 2023-03-31 | $5.08M | -16.70% |
| 2022-12-31 | $6.10M | -13.38% |
| 2022-09-30 | $7.04M | 100.00% |
| 2022-06-30 | - | -100.00% |
| 2022-03-31 | $5.84M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | - |
Spectral AI generated $3.79M in revenue during Q3 2025, up -25.13% compared to the previous quarter, and up 50.71% compared to the same period a year ago.
Spectral AI Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics | $146.07M | $44.04M |
| IPSC | Century Therapeutics | $109.16M | - |
| TELA | TELA Bio | $80.28M | $20.69M |
| ECOR | electroCore | $32.03M | $7.38M |
| SRTS | Sensus Healthcare | $27.48M | $6.88M |
| CTSO | Cytosorbents | $25.13M | $9.62M |
| MDAI | Spectral AI | $19.65M | $3.79M |
| ICCM | IceCure Medical | $3.23M | $736.35K |
| COEP | Coeptis Therapeutics | $1.36M | $62.87K |
| EQ | Equillium | $130.00K | - |
| TELO | Telomir Pharmaceuticals | - | - |